EditorialEditorial
Mission of the National Cancer Center Hospital in Japan to promote clinical trials for precision medicine
Kazuaki Shimada, Kenichi Nakamura and Noboru Yamamoto
Cancer Biology & Medicine February 2023, 20220643; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0643
Kazuaki Shimada
1Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo 104-0045, Japan
Kenichi Nakamura
2Clinical Research Support Office, National Cancer Center Hospital, Tokyo 104-0045, Japan
Noboru Yamamoto
3Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo 104-0045, Japan
References
- 1.↵
- 2.↵
- Kohno T.
- 3.
- Ebi H,
- Bando H.
- 4.↵
- 5.↵
- Sunami K,
- Takahashi H,
- Tsuchihara K,
- Takeda M,
- Suzuki T,
- Naito Y, et al.
- 6.↵
- 7.↵The Ministry of Health, Labour and Walfare Japan. The 4th Cancer Genome Medicine Consortium on March 5th, 2021 (in Japanese). https://www.mhlw.go.jp/content/10901000/000748554.pdf .
- 8.↵
- Okuma H,
- Yonemori K,
- Narita S,
- Sukigara T,
- Hirakawa A,
- Shimizu T, et al.
- 9.↵
- Sato J,
- Satouchi M,
- Itoh S,
- Okuma Y,
- Niho S,
- Mizugaki H, et al.
- 10.↵
- 11.↵
- 12.↵
In this issue
Mission of the National Cancer Center Hospital in Japan to promote clinical trials for precision medicine
Kazuaki Shimada, Kenichi Nakamura, Noboru Yamamoto
Cancer Biology & Medicine Feb 2023, 20220643; DOI: 10.20892/j.issn.2095-3941.2022.0643
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.